{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:58:41Z","timestamp":1793649521079,"version":"4.5.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012173","name":"China-Japan Friendship Hospital","doi-asserted-by":"publisher","award":["ZRJY2023-GG06"],"award-info":[{"award-number":["ZRJY2023-GG06"]}],"id":[{"id":"10.13039\/501100012173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300815"],"award-info":[{"award-number":["82300815"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.diabres.2026.113524","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:11:33Z","timestamp":1788451893000},"page":"113524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Trends in type 1 and type 2 diabetic kidney disease in China, the USA, and the UK, 1990\u20132023"],"prefix":"10.1016","volume":"241","author":[{"given":"Zhenkun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiansen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaigang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenge","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2026.113524_b0005","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1038\/nrdp.2015.18","article-title":"Diabetic kidney disease [J]","volume":"1","author":"Thomas","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.diabres.2026.113524_b0010","doi-asserted-by":"crossref","unstructured":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [J]. Lancet, 2020, 395(10225): 709-733. DOI:10.1016\/s0140-6736(20)30045-3.","DOI":"10.1016\/S0140-6736(19)32977-0"},{"key":"10.1016\/j.diabres.2026.113524_b0015","doi-asserted-by":"crossref","unstructured":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 [J]. Lancet, 2023, 402(10397): 203-234. DOI:10.1016\/s0140-6736(23)01301-6.","DOI":"10.1016\/S0140-6736(23)01301-6"},{"issue":"1","key":"10.1016\/j.diabres.2026.113524_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-023-06015-1","article-title":"Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes [J]","volume":"67","author":"Sridhar","year":"2024","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.diabres.2026.113524_b0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.ackd.2017.10.011","article-title":"The global epidemiology of diabetes and kidney disease [J]","volume":"25","author":"Koye","year":"2018","journal-title":"Adv Chronic Kidney Dis"},{"issue":"6","key":"10.1016\/j.diabres.2026.113524_b0030","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jama.2016.10924","article-title":"Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014 [J]","volume":"316","author":"Afkarian","year":"2016","journal-title":"J Am Med Assoc"},{"issue":"5","key":"10.1016\/j.diabres.2026.113524_b0035","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/CM9.0000000000003428","article-title":"Epidemiological status, development trends, and risk factors of disability-adjusted life years due to diabetic kidney disease: a systematic analysis of Global Burden of Disease Study 2021 [J]","volume":"138","author":"Li","year":"2025","journal-title":"Chin Med J (Engl)"},{"issue":"24","key":"10.1016\/j.diabres.2026.113524_b0040","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1001\/jama.2021.22208","article-title":"Prevalence and treatment of diabetes in China, 2013-2018 [J]","volume":"326","author":"Wang","year":"2021","journal-title":"J Am Med Assoc"},{"issue":"10204","key":"10.1016\/j.diabres.2026.113524_b0045","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0140-6736(19)32136-1","article-title":"10 years of health-care reform in China: progress and gaps in Universal Health Coverage [J]","volume":"394","author":"Yip","year":"2019","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.diabres.2026.113524_b0050","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.2018.3060","article-title":"Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007-2008 to 2015-2016 [J]","volume":"319","author":"Hales","year":"2018","journal-title":"J Am Med Assoc"},{"issue":"4","key":"10.1016\/j.diabres.2026.113524_b0055","first-page":"1","article-title":"United States: Health System Review [J]","volume":"22","author":"Rice","year":"2020","journal-title":"Health Syst Transit"},{"issue":"1","key":"10.1016\/j.diabres.2026.113524_b0060","first-page":"1","article-title":"United Kingdom: health system review [J]","volume":"24","author":"Anderson","year":"2022","journal-title":"Health Syst Transit"},{"key":"10.1016\/j.diabres.2026.113524_b0065","doi-asserted-by":"crossref","unstructured":"Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 [J]. Lancet, 2025, 406(10513): 1873-1922. DOI:10.1016\/s0140-6736(25)01637-x.","DOI":"10.1016\/S0140-6736(25)01637-X"},{"key":"10.1016\/j.diabres.2026.113524_b0070","doi-asserted-by":"crossref","unstructured":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 [J]. Lancet, 2024, 403(10440): 2133-2161. DOI:10.1016\/s0140-6736(24)00757-8.","DOI":"10.1016\/S0140-6736(24)00757-8"},{"issue":"10062","key":"10.1016\/j.diabres.2026.113524_b0075","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","article-title":"Guidelines for accurate and transparent health estimates reporting: the GATHER statement [J]","volume":"388","author":"Stevens","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.diabres.2026.113524_b0080","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates [J]","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"10.1016\/j.diabres.2026.113524_b0085","first-page":"1","article-title":"Guidance for selecting model options in the national cancer institute Joinpoint REGRESSION SOFTWAre [J]","volume":"194","author":"Irimata","year":"2022","journal-title":"Vital Health Stat 1"},{"key":"10.1016\/j.diabres.2026.113524_b0090","doi-asserted-by":"crossref","unstructured":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 [J]. Lancet, 2024, 403(10440): 2162-2203. DOI:10.1016\/s0140-6736(24)00933-4.","DOI":"10.1016\/S0140-6736(24)00769-4"},{"key":"10.1016\/j.diabres.2026.113524_b0095","article-title":"Factors associated with the uptake of national essential public health service package for hypertension and type-2 diabetes management in China's primary health care system: a mixed-methods study [J]","volume":"31","author":"Xiong","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"issue":"4","key":"10.1016\/j.diabres.2026.113524_b0100","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jamainternmed.2022.6817","article-title":"Prevalence of chronic kidney disease in China: results from the sixth china chronic disease and risk factor surveillance [J]","volume":"183","author":"Wang","year":"2023","journal-title":"JAMA Intern Med"},{"issue":"9","key":"10.1016\/j.diabres.2026.113524_b0105","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41581-024-00863-9","article-title":"The impact of population ageing on the burden of chronic kidney disease [J]","volume":"20","author":"Chesnaye","year":"2024","journal-title":"Nat Rev Nephrol"},{"issue":"20","key":"10.1016\/j.diabres.2026.113524_b0110","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the american heart association [J]","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.diabres.2026.113524_b0115","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities [J]","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113524_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100590","article-title":"Disparities in the use of SGLT2 inhibitors and glucagon-like peptide-1 receptor agonists in adults with CKD in the United States [J]","volume":"5","author":"Nicholas","year":"2023","journal-title":"Kidney Med"},{"issue":"9","key":"10.1016\/j.diabres.2026.113524_b0125","doi-asserted-by":"crossref","first-page":"e2852","DOI":"10.1210\/clinem\/dgaf301","article-title":"Overcoming disparities in using SGLT2 inhibitors for cardiorenal protection in persons with and without type 2 diabetes [J]","volume":"110","author":"Jack","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2026.113524_b0130","doi-asserted-by":"crossref","unstructured":"KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic KidneyDisease [J]. Kidney Int, 2021, 99(3s): S1-s87. DOI:10.1016\/j.kint.2020.11.003.","DOI":"10.1016\/j.kint.2020.11.003"},{"key":"10.1016\/j.diabres.2026.113524_b0135","doi-asserted-by":"crossref","unstructured":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease [J]. Kidney Int, 2024, 105(4s): S117-s314. DOI:10.1016\/j.kint.2023.10.018.","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"10.1016\/j.diabres.2026.113524_b0140","doi-asserted-by":"crossref","unstructured":"KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease [J]. Kidney Int, 2022, 102(5s): S1-s127. DOI:10.1016\/j.kint.2022.06.008.","DOI":"10.1016\/j.kint.2022.06.008"},{"issue":"7","key":"10.1016\/j.diabres.2026.113524_b0145","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S2213-8587(22)00099-7","article-title":"Incidence rate patterns, cumulative incidence, and time trends for moderate and severe albuminuria in individuals diagnosed with type 1 diabetes aged 0-14 years: a population-based retrospective cohort study [J]","volume":"10","author":"Jansson Sigfrids","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"10.1016\/j.diabres.2026.113524_b0150","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.2337\/dci22-0027","article-title":"Diabetes management in chronic kidney disease: a consensus report by the american diabetes association (ADA) and kidney disease: improving global outcomes (KDIGO) [J]","volume":"45","author":"de Boer","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113524_b0155","doi-asserted-by":"crossref","unstructured":"DCCT\/EDIC Research Group. Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study [J]. Lancet Diabetes Endocrinol, 2014, 2(10): 793-800. DOI:10.1016\/s2213-8587(14)70155-x.","DOI":"10.1016\/S2213-8587(14)70155-X"},{"issue":"24","key":"10.1016\/j.diabres.2026.113524_b0160","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy [J]","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726004444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726004444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:25:40Z","timestamp":1793121940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726004444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":32,"alternative-id":["S0168822726004444"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113524","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in type 1 and type 2 diabetic kidney disease in China, the USA, and the UK, 1990\u20132023","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113524"}}